Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
Front Neurol
.
2016 Sep 30:7:167.
doi: 10.3389/fneur.2016.00167.
eCollection 2016.
Authors
Arjan Blokland
1
,
Anke Sambeth
1
,
Jos Prickaerts
1
,
Wim J Riedel
1
Affiliation
1
Maastricht University , Maastricht , Netherlands.
PMID:
27746762
PMCID:
PMC5042959
DOI:
10.3389/fneur.2016.00167
No abstract available
Keywords:
Alzheimer; actelylcholine; cognition enhancer; deficit model; memory.